The Washington Download - Vol. 10 Issue 24
AMIA commented on FDA's request for public comment regarding real-world performance evaluation of AI-enabled medical devices. We support lifecycle governance with continuous post-market monitoring to address performance drift across diverse populations and settings. AMIA recommends comprehensive metrics beyond accuracy including clinical outcomes, safety, usability, and equity assessment. We emphasize transparent […]
As one of 450 stakeholders, AMIA calls on Congress for permanent Medicare telehealth legislation. The current lapse affects 4+ million beneficiaries and 30% of providers delivering virtual care, disrupting healthcare innovation and informatics infrastructure. Temporary extensions create instability impeding technology adoption and evidence-based implementation. AMIA supports retroactive payment restoration and […]
The White House Office of Science and Technology Policy (OSTP) issued a Request for Information (RFI) seeking public input on how existing federal laws and regulations may impede the development and adoption of artificial intelligence (AI). In response, AMIA urged regulatory reforms that promote responsible AI use in healthcare while […]